Author:
Tang Jing,Zhu Jiang,Ye Yuguang,Liu Yu,He Yan,Zhang Lei,Tang Dai,Qiao Cong,Feng Xinxin,Li Junyi,Kan Yanni,Li Xiaobo,Jin Xiaoming,Kong Dan
Funder
National Natural Science Foundation of China
Haiyan Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference24 articles.
1. Jayson GC, Kohn EC, Kitchener HC, Ledermann JA. Ovarian cancer. Lancet. 2014;384:1376–88.
2. Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61:183–203.
3. Pignata S, Cecere S, Du Bois A, Harter P, Heitz F. Treatment of recurrent ovarian cancer. Ann Oncol. 2017;11:28.
4. Morgan SL, Medina JE, Taylor MM, Dinulescu DM. Targeting platinum resistant disease in ovarian cancer. Curr Med Chem. 2014;21:3009–20.
5. Liu Yu, Tang Jing, Liu Duanyang, Zhang Lei, He Yan, Li Jing, et al. Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance. Cell Death Dis. 2018;9:419.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献